Search results for:

518 results

Dutch Supreme Court answers prejudicial questions on the interpretation of the concept 'essentially new constructed real estate' for VAT purposes

On Friday 4 November 2022, the Dutch Supreme Court answered prejudicial questions of the Zeeland-West Brabant District Court on the interpretation of the concept of ‘essentially new constructed real estate’ (in wezen nieuwbouw) for Dutch VAT purposes.

Stibbe advises Adevinta on Marktplaats acquisition

Stibbe has advised Adevinta on the acquisition of eBay Classifieds Group for a value of approximately USD 9.2 billion. eBay Classifieds Group operates a portfolio of leading marketplace brands in 13 countries, including Marktplaats in the Netherlands.

Stibbe advises Aedifica

Stibbe has advised Aedifica on the acquisition and lease of a care residence to be constructed in Lelystad and the acquisition and lease of a recently completed care residence in Zwolle.

Stibbe advises Aquiline Capital Partners

Stibbe advised Aquiline Capital Partners, a private equity firm based in New York investing in financial services enterprises, as lead counsel on the acquisition of the Quintes group together with existing management.

Emergency Act on Conditional Final Dividend Withholding Tax Levy submitted to Dutch parliament

On Friday 10 July 2020, a member of the Dutch opposition party Groenlinks has submitted an initiative legislative proposal for a Conditional Final Dividend Withholding Tax Levy Emergency Act (the 'Proposal') to Dutch parliament. The Proposal provides for

Breaking news from the CJEU: no SPCs for new therapeutic applications

On 9 July 2020, the Grand Chamber of the CJEU ruled on the interpretation of Article 3(d) of Regulation 469/2009 concerning the supplementary protection certificate (CCP) for medicinal products.

COVID-19 update and Guidelines published on the Dutch implementation of DAC6

The EU Mandatory Disclosure Directive (“DAC6”), introducing a reporting requirement for intermediaries and/or taxpayers of certain cross-border arrangements that are perceived to be aggressive, is effective as of 1 July in the Netherlands. By his letter o

Mandatory disclosure-verplichtingen voor grensoverschrijdende constructies (‘DAC6’)

Per 1 juli 2020 zijn intermediairs (en in sommige gevallen belastingplichtigen) gehouden om bepaalde potentieel fiscaal agressieve grensoverschrijdende constructies te melden bij de fiscale autoriteiten. Deze verplichting vloeit voort uit de Nederlandse i

Stibbe advises Satmex

Advising Satmex on its sale to Eutelsat for an Enterprise Value of USD 1.14 billion (including the Satmex debt assumed by Eutelsat).

Stibbe advises The Blackstone Group

Advising The Blackstone Group on the acquisition - and on the structuring and financing of this acquisition - of a logistics property portfolio in the Netherlands and Germany from Syntrus Achmea Real Estate Investment Fund.

Stibbe advises Qatar Petroleum International

Advising Qatar Petroleum International on the purchase of a stake in a Brazilian oil field from Shell for a purchase price of approximately USD 1 billion

Stibbe advises the Supervisory Board of Ziggo

Advising the Supervisory Board of Ziggo on a recommended public share exchange and cash offer by Liberty Global - and on other aspects of the transaction - to acquire the stake it doesn't hold in Ziggo.

Stibbe advises Vistra

Stibbe advises Smurfit Kappa

Advising Smurfit Kappa on the refinancing of its existing credit facilities.

Stibbe advises listed German group

Stibbe advised on the tax aspects of a listed German group's debt restructuring through a Luxembourg vehicle.

Stibbe advises Concentra

Stibbe advised Concentra on its joint venture with Corelio. The joint-venture between these two publishing companies will be called “Het Mediahuis”.

Stibbe advises group of investors led by Joh. A. Benckiser

Stibbe advised a group of investors led by Joh. A. Benckiser on its bid for all outstanding shares of D.E MASTER BLENDERS 1753 N.V.

Stibbe advises leading pharmaceutical company

Stibbe assisted a leading pharmaceutical company in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredients.

SearchSearch results for: “”